Les lipases, protéines ubiquitaires, sont les enzymes les plus étudiées et les plus utilisées dans l’industrie. Elles catalysent un très grand nombre de réactions, d’hydrolyse et de synthèse, conduisant à une grande diversité de molécules, acides, esters, amides…. Les domaines d’applications sont nombreux : les bio-énergies, les arômes, bio-lubrifiants, bio-plastifiants, émulsifiants, produits phytosanitaires et détergents, cosmétiques, synthons pour la chimie fine, produits pharmaceutiques… Aujourd’hui, grâce aux outils génétiques, il est possible de modifier leur activité, spécificité et thermostabilité pour les adapter idéalement aux contraintes industrielles. Dans ce travail de doctorat, nous nous sommes intéressés à quatre lipases d’intérêt industriel. Les 3 premières appartiennent à la famille des lipases de Candida rugosa (Lip1, Lip3 et Lip4). Bien que très homologues, leurs spécificités sont très différentes. Elles se distinguent de toutes les autres lipases par un site actif composé d’un long tunnel avec la triade catalytique à l’entrée de celui-ci. Cela en fait une enzyme particulièrement intéressante pour la conversion et la purification d’acides gras à longue chaîne. La quatrième est une nouvelle lipase identifiée chez la levure oléagineuse, Yarrowia lipolytica. Elle est très active sur les acides gras à longue chaîne, active à pH acide et présentant une grande énantiosélectivité sur des molécules d’intérêt pharmaceutique, les esters d’acide 2- halogéno-aryl acide acétique. Dans un premier temps, un nouveau système d’expression, une souche spécifique de Yarrowia lipolytica, a été étudié pour l’expression de variants construits par mutagenèse dirigée. Cette souche JMY1212 permet une intégration ciblée dans le génome de Y. lipoytica. Nous avons démontré qu’il s’agissait du premier système d’expression permettant de comparer statistiquement l’activité de variants directement à partir du surnageant de culture. Trois des lipases de Candida rugosa ont été clonées avec succès dans cette souche et leurs activités et spécificités vis-à-vis de la longueur de chaines des acides gras ont été étudiées. Lip1 et Lip3 présentent une spécificité pour les acides gras à longueur de chaine moyenne (C8-C10) alors que Lip4 préfère les C18:1. De, plus, pour la première fois, la purification, à partir d’un mélange d’esters éthyliques issu d’huile de poissons, d’acides gras poly-insaturés (PUFAs); acides cis-5, 8, 11, 14, 17-eicosapentaenoic (EPA) et cis-4, 7, 10, 13, 16, 19-docosahexaenoic (DHA), molécules bonnes pour la santé, a été réalisée avec les trois lipases séparées de C. rugosa. Quelle que soit l’enzyme, le rendement de récupération du DHA est supérieur à 93 % (97, 100 et 93 % pour Lip1, Lip3 et Lip4 respectivement. Une pureté maximale en DHA de ~60 % a été obtenue avec Lip3 et Lip4, à partir d’un mélange initial d’esters éthyliques contenant 25% de DHA. Une différence remarquable entre ces trois enzymes est que Lip4 est capable de mieux hydrolyser l’ester d’EPA (60% contre 14 et 16% pour Lip1 et Lip3). Lip4 est même capable d’hydrolyser le DHA (7% contre 3 et 0 % pour Lip1 et Lip3). La deuxième partie de ce travail a été consacrée à l’amélioration de l’énantiosélectivité des deux enzymes étudiées vis-à-vis de synthons d’intérêt dans l’industrie pharmaceutique, les esters de 2-bromo aryl acide acétique. La construction raisonnée d’un double variant de la lipase Lip2 de Y. lipolytica, D97AV232F, a permis d’obtenir une enzyme totalement énantiosélective (E >200). Celle-ci reconnaît l’énantiomère R alors que la lipase sauvage avait une faible préférence pour l’énantiomère S (E=5). Par ailleurs, cette exceptionnelle augmentation de l’énantiosélectivité s’accompagne d’une amélioration de l’activité de l’enzyme qui est ainsi multipliée par 4,5. Sur ce même mélange d’énantiomères, les 3 lipases de C. rugosa se sont avérées remarquables. Malgré leur grande homologie, leur spécificité est différente. Lip1 et Lip3 sont totalement S spécifiques (E>200), alors que Lip4 est R spécifique (E=15). Le docking moléculaire des énantiomères S et R dans le site actif des lipases Lip1 et Lip4 a permis de mieux comprendre ces différences de spécificité et de proposer des cibles de mutagenèse dirigée. L’encombrement et la nature de l’acide aminé présent en position 296 sont cruciaux pour la discrimination de l’enzyme / Lipases, ubiquitous proteins, are the most studied enzymes and the most used in industry. They catalyse a great number of reactions, hydrolysis and synthesis, leading to a great diversity of molecules, acids, esters, amides. There are numerous fields of applications: bio-energies, flavours, bio-lubricants, bio-plasticizers, emulsifiers, detergents, cosmetics, synthons for fine chemistry, and pharmaceutical products. Nowadays, thanks to genetic tools, it is possible to modify their activity, specificity and thermostability to ideally adapt enzymes for the industrial constraints. In this work, we were interested in four lipases of industrial interest. The third ones belong to the lipase family of Candida rugosa (Lip1, Lip3 and Lip4). Although they present high homology, their specificities are very different. They are distinct from the other lipases by the active site composed of a long tunnel with the catalytic triad at the entry of the tunnel. It leads to enzymes particularly interesting for the conversion and the purification of long chain fatty-acids. The fourth one is a new lipase identified from oleaginous yeast, Yarrowia lipolytica. It is one of the most active lipase on long chain fatty-acids; it is very active and stable at acid pH and presents a high enantioselectivity on molecules of pharmaceutical interest, the esters of 2- halogeno-aryl acetic acid. In this work, we first tested a new expression system, a specific strain of Y. lipolytica, for expression of variants obtained by site-directed mutagenesis. This strain JMY1212 enables integration to be targeted to a special locus of the Y. lipoytica genome. We demonstrated that it is the first expression system in which it is possible to compare statistically variant activities directly from the supernatant of the culture. Secondly, three lipases of C. rugosa were cloned successfully in this strain and their activities and specificities with respect to fatty acid chain lengths were studied. Lip1 and Lip3 have specificity for the fattyacids of medium chain (C8-C10) whereas Lip4 prefers C18: 1. Moreover, for the first time, purification, from a mixture of ethyl esters issued from fish oil, polyunsaturated fatty acids (PUFAs); cis-5, 8, 11, 14, 17- eicosapentaenoic acid (EPA) and cis-4, 7, 10, 13, 16, 19-docosahexaenoic acid (DHA), molecules with health benefits, was realised with the three C. rugosa lipases, separately. Whatever the enzyme the recovery of DHA is superior to 90 % (97, 100 and 93 % for Lip1, Lip3 and Lip4 respectively. The maximal DHA purity ~60 % was obtained with Lip3 and Lip4, with an initial ethyl ester mixture containing 25% DHA. A remarkable difference between these enzymes lies in the fact that Lip4 is able to better hydrolyse the EPA esters (60% against 13% and 16% respectively for Lip1 and Lip3). Lip4 is also able to hydrolyse DHA (7% against 3 and 0 % for Lip1 and Lip3 respectively). The third part of this work was devoted to the improvement of the enantioselectivity of the two enzymes studied with respect to the resolution of a racemic mixture of pharmaceutical industry, the R, S esters of 2-bromo aryl acetic acid. The rational construction of a double variant of Lip2 lipase from Y. lipolytica, D97A V232F was realized to obtain a total enantioselective enzyme (E > 200). This variant recognizes the enantiomer R whereas wild-type lipase had a weak preference for the enantiomer S (E=5). In addition, this exceptional increase in the enantioselectivity is accompanied by a 4.5 fold improvement of the activity. With the same mixture of enantiomers, the 3 lipases of C. rugosa proved to be remarkable from the point of view of enantioselectivity. In spite of their high homology, their specificity is different. Lip1 and Lip3 are completely specific for the S enantiomer, whereas Lip4 is R specific (E=15). The molecular docking of the S and R enantiomers in the active site of Lip1 and Lip4 lipases enables the observed differences in specificity to be better understood and targets for site-directed mutagenesis to be proposed. We demonstrated that the nature of the amino acid present in position 296 is crucial for the discrimination of these enzymes

Nesse projeto, foi desenvolvido um sistema biológico que denominamos Dosímetro de DNA, com o objetivo de avaliar a ação genotóxica da radiação UV solar a partir da produção de lesões na molécula de DNA. Para determinar os diferentes tipos de danos, utilizamos enzimas de reparo de DNA e anticorpos específicos. Complementando estas análises, foram ainda realizados ensaios de frequência de mutação e da taxa de inativação biológica de DNA. Através da utilização dessa tecnologia foi possível confirmar a produção de lesões CPDs e 6-4PPs após a irradiação em lâmpadas de UVB e UVA. Outro fator importante foi a maior indução de danos oxidativos que a banda de UVA apresentou em relação à de UVB. Exposições ambientais demonstram claramente que a luz solar possui diferentes perfís de indução de lesões de DNA, que variam de acordo com a localidade da irradiação, e que fenômenos biológicos como inativação de DNA e mutagênese são diretamente dependentes da presença de fotoprodutos na molécula de DNA e não estão associados aos danos oxidativos. Portanto, o sistema Dosímetro de DNA é capaz de fornecer uma ampla compreensão da ação genotóxica da luz solar e informações inovadoras que poderão ser utilizadas no desenvolvimento de substâncias fotoprotetoras mais eficientes. / To better understand the impact of solar UV radiation upon DNA molecule, we developed a biological system based on the exposure of plasmid DNA to artificial and natural UV sources. The quantification of DNA lesions was performed through the use of specific DNA repair enzymes and antibodies. The biological effects of sunlight, as well as artificial UV-radiation, were evaluated through the determination of the DNA inactivation rate and mutagenesis frequency. Through the application of this technology, we could detect the induction of CPDs and 6-4PPs after exposures to UVB and UVA lamps. Interestingly, the induction of oxidative damages was significantly higher after UVA than UVB radiation. Surprisingly, the profiles of induction of DNA damages observed after sunlight exposures have presented variations especially according to the latitude. In addition, our data clearly indicate that the induction of these biological effects is directly related to the presence of photoproducts in UV-exposed DNA samples, and suggest that oxidative damages are not related to these biological processes. Therefore, a very suitable system was developed capable of providing a wide comprehension of the biological effects of solar-UV radiation upon the DNA molecule.

Os vetores retrovirais representam uma das melhores opções para transferência e terapia gênica, pois fornecem expressão do transgene em longo prazo. Entretanto, a inserção do provírus pode causar mutagênese insercional, induzindo proto-oncogenes. Eventos deste tipo têm sido descritos em protocolos clínicos para o tratamento de SCID-X1, doença granulomatosa crônica e talessemia beta, quando vetores retrovirais (oncorretrovirus) foram utilizados. Atualmente, existem poucos métodos simples e rápidos para revelar e quantificar a expansão clonal. Assim, descrevemos a construção uma biblioteca de vetores contendo uma marcação aleatória, denominada código de barras. O sequenciamento do código de barras permitirá revelar, caracterizar e até quantificar a expansão clonal de uma população de células transduzidas. Esta metodologia ajudará a testar novos arranjos de promotores e genes terapêuticos, para o desenvolvimento de vetores mais seguros contribuindo para a redução da probabilidade de um evento de proliferação clonal desencadeado pela mutagênese insercional. / Retroviral vectors represent one of the best options for gene transfer and therapy, where long-term transgene expression is required. However, insertion of the provirus can cause insertional mutagenesis, which may have adverse consequences, such as induction of proto-oncogenes. Such events have been described in clinical trials for the treatment of SCID-X1, chronic granulomatous disease and beta thalessemia with some retroviral vectors. Currently, there are few simple and quick methods that can reveal and quantify clonal expansion. Thus, we describe the construction of a vector library containing random markers, called \"barcodes\". The sequencing of the barcode could reveal, characterize and quantify the clonal expansion of a transduced cells population. This methodology will be valuable to test new arrangements of promoters and therapeutic genes, allowing the development of safer vectors, helping to reduce the probability of clonal proliferation events triggered by insertional mutagenesis.

A flavonol specific glucosyltransferase cloned from Citrus paradisi has strict substrate and regio-specificity (Cp3OGT). The amino acid sequence of Cp3OGT was aligned with sequences of an anthocyanidin UDP- dependant glucosyltransferase (UGT) from Clitorea ternatea and a UGT from Vitis vinifera that can glucosylate both flavonols and anthocyanidins. Using homology modeling to identify candidate regions followed by site directed mutagenesis, three double mutations were constructed and biochemically characterized. S20G+T21S mutant protein retained activity with flavonols similar to the wildtype Cp3OGT but the mutant had optimum activity at 60°C and broadened substrate acceptance to include the flavanone naringenin. S290C+S319A mutant protein retained 40% activity with quercetin relative to WT, and had an optimum pH shift. H154Y+Q87I mutant protein was only 10% active with quercetin relative to WT. Docking analysis revealed that H154, Q87 and S20 could be involved in orienting the acceptor molecules within the acceptor binding site whereas S319 and S290 residues are involved in maintaining the active site conformation.

Human C-reactive protein (CRP) is the prototypic acute phase protein whose serum concentration increases rapidly during inflammation. CRP is also associated with atherosclerosis; it is deposited at lesion sites where it may interact with modified lipoproteins. There are 2 major questions regarding CRP: 1. How is the serum concentration of CRP regulated? 2. What are the functions of CRP in atherosclerosis? Our first aim was to determine the role of the constitutively expressed transcription factor Oct-1 in regulating CRP gene expression. We found that Oct-1 overexpression inhibited (IL-6+IL-1β)- induced CRP gene expression; maximal inhibition required the binding of Oct-1 to an octamer motif at (-59 to -66) on the CRP promoter. Oct-1 overexpression inhibited both (IL-6+IL-1β)- induced and C/EBPβ-induced CRP gene expression even when the Oct-1 site was deleted. These findings suggest that Oct-1 is a repressor of CRP gene expression that acts via binding to its cognate site on the CRP promoter as well as through indirect interactions with other promoterbound transcription factors. Our second aim was to investigate the interaction of CRP with oxidized low density lipoprotein (ox-LDL). Acidic pH, a hallmark of atherosclerotic lesions, reversibly alters CRP structure and exposes a hidden binding site that enables CRP to bind ox-LDL. Using site-directed mutagenesis we constructed a CRP mutant (E42Q) that showed significant binding to ox-LDL at physiological pH. E42Q CRP required a less acidic pH for maximal binding and bound ox-LDL more efficiently than wild type CRP at any pH. We then examined if reactive oxygen species also induced CRP – ox-LDL interaction. H2O2-treated CRP bound ox-LDL at physiological pH. Like acidic pH, H2O2-treatment induced only a local structural change exposing the ox-LDL binding site. E42Q and H2O2-modified CRP are tools to study the function of CRP in animal models of atherosclerosis, which may not have an inflammatory environment sufficient to modify CRP and induce binding to atherogenic ox-LDL. We conclude that Oct-1 is one of the critical regulators of CRP gene expression, and that CRP can be modified in vitro to convert it into an atherogenic LDL-binding molecule.

Most naturally-occurring fl avonoids are found in glucosylated form. Glucosyltransferases (GTs) are enzymes that catalyze the transfer of glucose from a high energy sugar donor to an acceptor molecule. Citrus paradisi fl avonol-specifi c glucosyltransferase (Cp-F3-O-GT) is recognized for its rigid substrate and regiospecifi city. In this work, homology modeling, site-directed mutagenesis, and biochemical analyses of the recombinant mutant Cp-F3-O-GT proteins were used to investigate potential amino acid residues that might be responsible for the enzymes strict regiospecifi city while also investigating its substrate specifi city. The single point mutations of three amino acid residues within the grapefruit F3-O-GT identifi ed through sequence alignment and homology modeling were performed. Analyses of the enzyme activity of the recombinant mutant F3-O-GT proteins revealed that the single point mutations of serine 20 to leucine (S20L) and proline 297 to phenylalanine (P297F) rendered the recombinant enzymes inactive with fl avonol substrates at 6% and 12% respectively relative to wild-type. However, the mutation of glycine 392 to glutamate (G392E) remained active and glucosylated the fl avonol acceptors quercein (Km app= 11 μM; Vmax = 5.7 pKat/μg) relative to the wild-type (Km app= 93 μM; Vmax = 41.7 pKat/μg), and kaempferol (Km app= 7 μM; Vmax = 3.8 pKat/μg) relative to the wild-type (Km app = 39 μM; Vmax = 4.2 pKat/ μg). The mutant enzyme also did not show broadened acceptor substrate specifi city as it also favored fl avonols as the preferred acceptor substrate. The optimum pH of the mutant enzyme was 8.0 similar to the wild-type F3-O-GT. Activity of the mutant enzyme was stimulated by NaCl and KCl, but inhibited by Cu2+, Zn2+, Fe2+ as well as UDP with an apparent Ki of 10μM. Product identifi cation to determine glucosylation position is being investigated for a possible change in regiospecifi city.

Chez l’homme, la dégradation des fibres alimentaires est une des fonctions principales du microbiote colique. Elles ont de nombreux effets bénéfiques en santé humaine et pourtant les mécanismes microbiens mis en jeu dans leur dégradation restent encore largement méconnus. L’objectif de cette thèse était d’approfondir les connaissances sur la dégradation des polysaccharides pariétaux (hémicelluloses et pectines) par une espèce bactérienne prédominante du côlon de l’homme, Bacteroides xylanisolvens. L’analyse du transcriptome de B. xylanisolvens XB1AT a révélé l’existence de six et deux loci génomiques respectivement dédiés à la dégradation des pectines et des xylanes. Ces loci ou PULs (« Polysaccharide Utilization Loci ») sont connus chez Bacteroides pour coder pour des systèmes enzymatiques spécifiques d’un polysaccharide en particulier. L’analyse des CAZymes (Carbohydrate-Active Enzymes) codées par les PULs « pectinolytiques » a permis de proposer une cible polysaccharidique (homogalacturonane, rhamnogalaturonane de type I et II, arabinane) à cinq des six PULs identifiés. Les deux PULs « xylanolytiques » cibleraient les xylanes de faible complexité. La mutation du gène susC-like dans le PUL 49 et du gène HTCS (Hybrid Two-Component System) dans le PUL 43 a démontré l’importance respective de ces deux loci dans la fonction pectinolytique et xylanolytique de la bactérie. Le mutant HTCS a aussi permis de montrer pour la première fois que deux PUL peuvent être liés au niveau transcriptionnel. En présence de xylane, les données de protéomique ont souligné la surproduction par la bactérie d’une endo-xylanase possédant deux CBMs (Carbohydrate-Binding Modules). Cette enzyme modulaire pourrait être considérée comme un marqueur fonctionnel de la xylanolyse dans l’écosystème microbien intestinal. En conclusion, B. xylanisolvens déploie une machinerie enzymatique qui reflète la complexité des polysaccharides pariétaux de plantes. La plasticité métabolique de B. xylanisolvens vis-à-vis des fibres alimentaires contribue certainement à sa survie et son maintien dans le côlon humain. Des études d’écologie fonctionnelle ciblant la communauté fibrolytique intestinale sont encore nécessaires afin de mieux décrypter l’impact des fibres alimentaires et en particuliers des polysaccharides pariétaux sur le métabolisme microbien intestinal et par conséquent sur la santé humaine. / Dietary fiber degradation is a key function of the human gut microbiota. They have many beneficial effects on human health and yet microbial mechanisms involved in their degradation remain largely unknown. The aim of this thesis was to increase our knowledge on the degradation of plant cell wall polysaccharides (hemicelluloses and pectins) by a prominent human gut bacterial species, Bacteroides xylanisolvens. The transcriptome analysis of B. xylanisolvens XB1AT revealed the existence of six and two genomic loci dedicated to the degradation of pectins and xylan, respectively. These loci or PUL ("Polysaccharide Utilization Loci") are known to encode enzyme systems in Bacteroides that are specific to a particular polysaccharide. Analysis of the CAZymes (Carbohydrate-Active Enzymes) encoded by the "Pectinolytic" PULs allowed us to propose a polysaccharide target (homogalacturonan, type I and type II rhamnogalaturonane, arabinan) to five of the six identified PULs. The two identified "xylanolytic" PULs would target low complexity xylan. Mutation of the susC-like gene of PUL 49 and of the HTCS gene (Hybrid Two-Component System) of PUL 43 showed the importance of these two loci in pectinolytic and xylanolytic functions of the bacterium, respectively. The HTCS mutant also revealed for the first time that two PULs can be linked at the transcriptional level. With xylan, proteomic data highlighted the overproduction by the bacterium of an endo-xylanase with two CBMs (Carbohydrate-Binding Modules). This modular enzyme could be considered as a functional marker of xylan breakdown in the intestinal microbial ecosystem. In conclusion, B. xylanisolvens harbors an enzymatic machinery that reflects the complexity of plant cell wall polysaccharides. The metabolic plasticity of B. xylanisolvens towards dietary fibers certainly contributes to its fitness in the human gut. Functional and ecological studies targeting the intestinal fibrolytic community are still necessary to better understand the impact of dietary fibers and in particular plant cell wall polysaccharides on the intestinal microbial metabolism and consequently on human health.

Les systèmes bioélectroniques tels que les biopiles enzymatiques nécessitant souvent l'utilisation des assemblages moléculaires complexes comprenant le cofacteur de l'enzyme, des agents de couplage et des médiateurs électrochimiques. Afin de les simplifier, nous avons remplacé ces différents partenaires par 13 analogues simples à synthétiser après identification par criblage in silico. Le noyau aromatique est couplé à un noyau aromatique et puis un médiateur électrochimique est couplé à celui-ci. Les produits sont des poudres de couleurs variées (rose, rouge). Le rendement de la première étape est de 83% avec une pureté d'environ 92%. Le rendement de la seconde étape est compris entre 45% et 65% avec une pureté de 97%. Ces analogues ont été caractérisés chimiquement (RMN, spectrométrie de masse) et électrochimiquement (voltammétrie cyclique et spectroélectrochimie). Les activités de deux enzymes, la formiate déshydrogénase (FDH) et l'alcool déshydrogénase de foie de cheval (HLADH), et d'un catalyseur organométallique, le [Cp*Rh(bpy)(H2O)]2+, ont été évaluées avec ces analogues. De faibles activités ont été observées en présence de l'HLADH avec 4 analogues et en présence de la FDH avec un seul analogue. Au contraire aux enzymes, la réduction d'un médiateur a pu été confirmée en présence du catalyseur [Cp*Rh(bpy)(H2O)]2+ par voltammétrie cyclique. La FDH native n'est pas adaptée à fonctionner avec ces nouveaux substrats solubles dans un LI, le [MMIm][Me2PO4]. Une FDH tolérante (N187S/T321S) au [MMIm][Me2PO4] précédemment obtenue par évolution dirigée a été donc étudiée en isolant les simples mutants N187S et T321S. Le double mutant N187S/T321S et le simple mutant N187S sont 4 fois plus actifs en solution aqueuse et en présence de LI. Des analyses par spectroscopie de fluorescence ont montré que la simple mutation N187S favorise la stabilité du dimère de FDH en modifiant le pKa de l'acide aminé E163. Celui-ci est impliqué dans la thermostabilité et la tolérance des FDHs aux LIs / Bioelectrical systems, such as enzymatic biofuel cells, often require a molecular construction complex comprising the enzyme cofactor, intermediary molecules and electrochemical mediators. In order to simplify them, we have replaced these different partners by 13 analogs that are simple to synthesize after identification by screening in silico. The nicotinamide ring is coupled to an aromatic moiety and an electrochemical mediator is then coupled to it as well, resulting in various colored powders (pink, red). The first step' s yield is around 83% with a purity of approximately 92%. The second step's yield is comprised between 45% and 65% with a purity of 97%. The analogs were characterized chemically (NMR, mass spectrometry) and electrochemically (cyclic voltammetry, spectroelectrochemistry). The activities of two enzymes, the formate dehydrogenase (FDH) and the horse liver alcohol dehydrogenase (HLADH), and an organometallic catalyst, [Cp*Rh(bpy)H2O]2+, were evaluated with these analogs. Weak activities were observed for 4 analogs using the HLADH and 1 analog using the FDH. Unlike the enzymes, the reduction of a conjugated mediator was confirmed with the catalyst [Cp*Rh(bpy)H2O]2+ using cyclic voltammetry. The wild type FDH is not adapted to function with these new substrates, which can be solubilized in an IL such as [MMIm][Me2PO4]. An FDH (N187S/T321S) shown to be tolerant to [MMIm][Me2PO4], and obtained previously by directed evolution, was studied by isolating the two single mutants, N187S and T321S. The double mutant N187S/T321S and the mutant N187S are 4 times more active in aqueous solution and in [MMIm][Me2PO4]. Fluorescence spectroscopy analyses showed that the single mutation N187S favorises FDH dimer stability by modifying the pKa of the amino acid E163. The latter is involved in FDH thermal stability and tolerance in ILs

<p>Neuropeptide Y (NPY) is known to influence a vast number of physiological and behavioral processes such as vasoconstriction, circadian rhythms, feeding, anxiety and memory. Peptides of the NPY family bind to five different cloned G-protein coupled receptor subtypes (Y1, 2, 4-6). The studies compiled in this thesis present inter-species comparisons of sequence similarities, binding properties and expression patterns among receptors of the NPY family.</p><p>Cloning of Y1 and Y2 receptor subtypes from guinea pigs revealed strong binding profile similarity to the corresponding human receptors. Previously demonstrated atypical binding profiles in the caval vein of guinea pigs were concluded to result from other receptors than the cloned Y1 and Y2 receptors, or possibly combinations of distinct receptor subtypes.</p><p>The guinea pig Y5 receptor was found to be expressed in regions of the brain that have been indicated as important for regulation of food intake. Expression in the hypothalamus, amygdala and brain stem was noticed, similar to studies in rats and humans. In other brain regions, such as the striatum and hippocampus, some species differences were observed.</p><p>Mutagenesis studies of the human Y1 receptor indicated sites important for binding both of endogenous agonists and synthetic antagonists. Putative new sites of interaction with the Y1 antagonists BIBP3226 and/or SR120819A were recognized. The data were used to construct a three-dimensional structure model, based on a high-resolution bovine rhodopsin model.</p><p>Cloning of the chicken (<i>Gallus gallus</i>) Y1, Y2 and Y5 receptors revealed high sequence similarities with mammalian receptors. Most endogenous ligands bound with similar affinities as to mammalian receptors. The strongest exception was the discovery of high-affinity binding to chicken Y2 of [Leu³¹, Pro³⁴]NPY, which was previously considered to bind non-Y2 receptors only. </p><p>The new human Y1 receptor model provides a basis for further investigations of ligand-receptor interactions which will be aided by information on NPY receptors from other taxa. Guinea pigs are concluded to be a good complement to rats and mice for studying NPY signaling. These results demonstrate the benefits of species comparisons for pharmacological studies.</p>

Neuropeptide Y (NPY) is known to influence a vast number of physiological and behavioral processes such as vasoconstriction, circadian rhythms, feeding, anxiety and memory. Peptides of the NPY family bind to five different cloned G-protein coupled receptor subtypes (Y1, 2, 4-6). The studies compiled in this thesis present inter-species comparisons of sequence similarities, binding properties and expression patterns among receptors of the NPY family. Cloning of Y1 and Y2 receptor subtypes from guinea pigs revealed strong binding profile similarity to the corresponding human receptors. Previously demonstrated atypical binding profiles in the caval vein of guinea pigs were concluded to result from other receptors than the cloned Y1 and Y2 receptors, or possibly combinations of distinct receptor subtypes. The guinea pig Y5 receptor was found to be expressed in regions of the brain that have been indicated as important for regulation of food intake. Expression in the hypothalamus, amygdala and brain stem was noticed, similar to studies in rats and humans. In other brain regions, such as the striatum and hippocampus, some species differences were observed. Mutagenesis studies of the human Y1 receptor indicated sites important for binding both of endogenous agonists and synthetic antagonists. Putative new sites of interaction with the Y1 antagonists BIBP3226 and/or SR120819A were recognized. The data were used to construct a three-dimensional structure model, based on a high-resolution bovine rhodopsin model. Cloning of the chicken (Gallus gallus) Y1, Y2 and Y5 receptors revealed high sequence similarities with mammalian receptors. Most endogenous ligands bound with similar affinities as to mammalian receptors. The strongest exception was the discovery of high-affinity binding to chicken Y2 of [Leu31, Pro34]NPY, which was previously considered to bind non-Y2 receptors only. The new human Y1 receptor model provides a basis for further investigations of ligand-receptor interactions which will be aided by information on NPY receptors from other taxa. Guinea pigs are concluded to be a good complement to rats and mice for studying NPY signaling. These results demonstrate the benefits of species comparisons for pharmacological studies.